ZEE Business
ZEE BUSINESS
Live TV
Live TV
  • India
    • Economy
    • Politics
    • Markets
  • World
    • Economy
    • Politics
    • Markets
  • Companies
    • Auto
    • Banking & Financial Services
    • Pharma
    • Energy
    • Infrastructure
    • Media
    • IT
    • Telecom
    • Consumer Products
    • Aviation
    • FMCG
  • Market
    • Mutual Funds
    • Commodity
  • Personal Finance
    • Income Tax Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • Home Loan Calculator
  • Technology
  • Automobile
    • Cars
    • Bikes
  • Small Business
    • SME
    • Startups
  • videos
  • photos
  • Authors
  • More ...
    • VIDEOS
    • PHOTOS
    • AUTHORS
Home » World News

Investor in Martin Shkreli's fund says he made millions

  • Twitter
  • Facebook
  • GPlus
Investor in Martin Shkreli's fund says he made millions
FILE PHOTO: Martin Shkreli, former chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc, departs after a hearing at U.S. Federal Court in Brooklyn, New York. Pic: Reuters
By Reuters
Updated: Thu, Jul 06, 2017
09:15 am
Reuters

One of the investors former drug company executive Martin Shkreli is accused of defrauding testified on Wednesday that Shkreli lied to him repeatedly, although he eventually made millions of dollars from the investment.

Darren Blanton, a Dallas-based biotechnology investor who appeared in Brooklyn federal court as a witness for U.S. prosecutors, told jurors he invested in Shkreli`s hedge fund MSMB Capital after being told the fund was managing $35 million in assets and had an independent auditor.

He said he later learned both of those claims were false and found Shkreli evasive when he tried to get some of his money back. Blanton said he eventually filed a whistleblower complaint with the U.S. Securities and Exchange Commission.

Under cross-examination by Shkreli`s lawyer, Benjamin Brafman, Blanton conceded that despite his misgivings, his $1.25 million investment with Shkreli paid off, largely through an agreement in which Shkreli gave him shares in his drug company Retrophin Inc.

Blanton said he still holds 150,000 shares of Retrophin, worth nearly $3 million at Wednesday`s closing price of $19.83 per share, and previously sold shares worth $2.4 million. He also said he received a cash payment of $200,000.

Prosecutors have claimed the agreement between Blanton and Shkreli, termed a consulting agreement, was a sham.

Blanton said Shkreli founded Retrophin after learning that a friend of Blanton`s had lost a son to a rare disease, myotubular myopathy, and vowed to find a cure.

Brafman`s cross-examination is expected to continue on Thursday.

The testimony came after U.S. District Judge Kiyo Matsumoto ordered Shkreli to stop talking about his case in or around the Brooklyn courthouse where the trial is taking place. Five days earlier Shkreli had burst into a room full of spectators and attacked the credibility of a government witness.

Shkreli, 34, gained notoriety in 2015 when he raised the price of a life-saving drug by 5,000 percent as CEO of Turing Pharmaceuticals, sparking outrage among patients and U.S. lawmakers. He at times revelled in the negative publicity as he came to be known as "pharma bro" and his Twitter harassment of a journalist led to him being banned from the social media platform.

The charges he now faces stem not from his time at Turing, but from his management of MSMB Capital, another fund called MSMB Healthcare and Retrophin between 2009 and 2014. Prosecutors say he deceived investors in the funds and eventually repaid them with money stolen from Retrophin.
 

TAGS:
Martin ShkreliTuring PharmaceuticalsKaloBios Pharmaceuticals IncPharmaPharmaceuticalsEconomydrug pricesMedicines
Next Article

NEXT STORY: Asia shares shaky, oil recovers after slump on OPEC export rise

RELATED NEWS

LATEST NEWS

PSEB 12th result 2018: Punjab Board Class 12 results declared on pseb.ac.in; how to download your results

Want to get Rs 50,000? Just do this thing for Maharashtra govt

This Mumbai restaurant still forces customers to pay service charge; check shocking case

These flat owners in Mumbai societies pay Rs 40 cr in water charges; check why

TCS second Indian firm to cross $100 bn; guess the first one!

TCS $100 bn market cap makes new history; outruns Sensex, Nifty and many others

October Box Office collection: Varun Dhawan maintains zero flops record, as take rises to Rs 39.33 crore

NSCL recruitment 2018: National Seeds Corporation notification for jobs on offer out; check indiaseeds.com

New industrial policy finalised, to be announced soon: Suresh Prabhu

Chip by chip: Narendra Modi govt sets this big 2020 deadline

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Contact Us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • Amazon Prime Day
  • Income Tax
  • Bharti Airtel
  • NPA
  • Home Loan

Trending Topics

  • Farm Loans
  • 7th Pay Commission
  • Sanitary Pads
  • National Stock Exchange
  • GST

Follow us on

zeebiz
zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • DNA
  • WION
Copyright © Zee Media Corporation Ltd. All rights reserved